DEA X-Waiver Expands Access to Treatment for Opioid Use Disorder

In this video, Dr. Bobby Redwood, WHA Physician Quality Improvement Advisor, and emergency physician and subject matter expert on opioid stewardship and medication safety, informs prescribers about changes by the DEA that eliminate certain X-Waiver requirements to prescribe buprenorphine for opioid use disorder treatment intended to expand access to medication-assisted treatment. (Video length is 1:26 minutes)